OPTINOSE, INC. Deferred Offering Costs
OPTINOSE, INC. had Deferred Offering Costs of $2.29 million as of 2017-09-30, per its 10-Q filed 2017-11-27.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2017-11-27
- 2017-09-30: Deferred Offering Costs $2.29M.
- 2016-12-31: Deferred Offering Costs $0.00.
| Period end | Deferred Offering Costs |
|---|---|
| 2017-09-30 | $2.29M 10-Q · filed 2017-11-27 |
| 2016-12-31 | $0.00 10-Q · filed 2017-11-27 |